疑似冠心病患者中临床未识别心肌纤维化的影像学评估
SPINS多中心研究纳入2349例疑似冠心病患者,以负荷心脏磁共振评估临床未识别心肌梗死(UMI)与临床识别心肌梗死(RMI)的预后价值。中位随访5.4年,UMI检出率14.8%,RMI为15.2%;校正缺血与左室射血分数后,UMI与RMI对死亡和/或心梗及MACE均保持独立预后关联。
要点
- UMI在疑似冠心病患者中检出率14.8%,与RMI相近,但指南导向药物治疗率更低。
- 校正缺血和左室射血分数后,UMI与死亡和/或心梗独立相关(HR 1.82)。
- UMI患者心衰住院风险高于RMI患者(HR 2.60),值得进一步研究。
核心结论
- 在疑似冠心病患者中,UMI或RMI的存在均提示死亡和/或心梗的显著风险,且独立于缺血的存在。
- 与RMI患者相比,UMI患者接受指南导向药物治疗的可能性更低,且心衰住院风险增加,值得进一步研究。
研究设计与样本
- 多中心SPINS研究纳入2349例连续疑似冠心病患者,年龄63±11岁,53%为男性,接受负荷心脏磁共振评估并随访中位5.4年。
- UMI定义为无心肌梗死病史但晚期钆增强符合心肌梗死表现。
主要发现
- UMI检出347例(14.8%),RMI检出358例(15.2%)。
- 与RMI患者相比,UMI患者心血管危险因素负担相似,但左室射血分数显著更低(p<0.001),阿司匹林(p<0.001)、他汀(p<0.001)和β受体阻滞剂(p=0.002)使用率更低。
- 随访期间发生328例死亡和/或心梗及528例MACE。
- 单变量分析中,UMI与死亡和/或心梗相关(HR 2.15;95%CI 1.63-2.83;p<0.001),RMI亦相关(HR 2.45;95%CI 1.89-3.18),两者均与MACE相关。
- 与RMI患者相比,UMI患者心衰住院风险增加(HR 2.60;95%CI 1.48-4.58;p<0.001)。
临床怎么用
- 负荷心脏磁共振检出UMI或RMI可用于疑似冠心病患者的风险分层,独立于缺血和左室射血分数。
- UMI患者指南导向药物治疗使用率较低,临床应关注此类患者并考虑优化药物治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stress cardiac magnetic resonance (CMR) provides accurate assessment of both myocardial infarction (MI) and ischemia. OBJECTIVES: This study aimed to evaluate the incremental prognostic value of unrecognized myocardial infarction (UMI), detected during assessment of coronary artery disease (CAD) by stress CMR, beyond cardiac function and ischemia. METHODS: In the multicenter SPINS (Stress CMR Perfusion Imaging in the United States) study, 2,349 consecutive patients (63 ± 11 years of age, 53% were male) with suspected CAD were assessed by stress CMR and followed over a median of 5.4 years. UMI was defined as the presence of late gadolinium enhancement consistent with MI in the absence of medical history of MI. This study investigated the association of UMI with all-cause mortality and nonfatal MI (death and/or MI), and major adverse cardiac events (MACE). RESULTS: UMI was detected in 347 patients (14.8%) and clinically recognized myocardial infarction (RMI) in 358 patients (15.2%). Compared with patients with RMI, patients with UMI had a similar burden of cardiovascular risk factors, but significantly lower left ventricular ejection fraction (p < 0.001) and lower rates of guideline-directed medical therapies, including aspirin (p < 0.001), statin (p < 0.001), and beta-blockers (p = 0.002). During follow-up, 328 deaths and/or MIs and 528 MACE occurred. In univariate analysis, UMI and RMI were strongly associated with death and/or MI (UMI: hazard ratio [HR]: 2.15; 95% confidence interval [CI]: 1.63 to 2.83; p < 0.001; RMI: HR: 2.45; 95% CI: 1.89 to 3.18) and MACE. Compared with patients with RMI, patients with UMI presented an increased risk for heart failure hospitalization (UMI vs. RMI: HR: 2.60; 95% CI: 1.48 to 4.58; p < 0.001). In a multivariate model including ischemia and left ventricular ejection fraction, UMI and RMI maintained robust prognostic association with death and/or MI (UMI: HR: 1.82; 95% CI: 1.37 to 2.42; p < 0.001; RMI: HR: 1.54; 95% CI: 1.14 to 2.09) and MACE. CONCLUSIONS: In a multicenter cohort of patients with suspected CAD, presence of UMI or RMI portended an equally significant risk for death and/or MI, independently of the presence of ischemia. Compared with RMI patients, those with UMI were less likely to receive guideline-directed medical therapies and presented an increased risk for heart failure hospitalization that warrants further study. (Stress CMR Perfusion Imaging in the United States [SPINS]; NCT03192891).
引用
- Antiochos P, Ge Y, Steel K, et al. Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease. J Am Coll Cardiol. 2020. PMID: 32819469. doi:10.1016/j.jacc.2020.06.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。